• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 37 of 100
Tobacco giants are getting into the coronavirus vaccine race
HealthTobacco giants are getting into the coronavirus vaccine race
By Sy MukherjeeMay 21, 2020
Moderna coronavirus vaccine trial
HealthModerna releases promising—but early—new coronavirus vaccine data
By Sy MukherjeeMay 18, 2020
ZOE.07.20.Kristin-Peck
MagazineThe CEO who keeps animal pharm growing
By Anne SradersMay 16, 2020
Antibody testing will be key—once we understand what the results mean
HealthAntibody testing will be key—once we understand what the results mean
By Sy MukherjeeMay 12, 2020
Gilead remdesivir price
NewslettersGilead’s moral (and financial) COVID-19 conundrum
By Sy MukherjeeMay 7, 2020
Gilead-Sciences-Remdesivir
HealthRemdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By Sy MukherjeeMay 1, 2020
COVID forgotten communities
NewslettersThe communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
HealthGilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
The coronavirus pandemic is impacting critical research into neuromuscular diseases
HealthThe coronavirus pandemic is impacting critical research into neuromuscular diseases
By Sy MukherjeeApril 28, 2020
People observing social distancing rules while waiting in line outside a Walgreens Pharmacy in New York City.
TechHow a pharmacy delivery startup has capitalized on the coronavirus pandemic
By Jeremy KahnApril 21, 2020
Big Pharma has the chance to come to the world’s rescue
MagazineBig Pharma has the chance to come to the world’s rescue
By Sy MukherjeeApril 20, 2020
A pharmacist counts prescription drugs at the at the CentreTown Pharmacy.
CommentaryPrescription drug costs are spiraling, but price controls are the wrong solution
By Karen KerriganApril 18, 2020
The key problem to solve in the quest for coronavirus treatments
NewslettersThe key problem to solve in the quest for coronavirus treatments
By Sy MukherjeeApril 9, 2020
How the best workplaces in health care and biopharma are responding to COVID-19
HealthHow the best workplaces in health care and biopharma are responding to COVID-19
By Ed FrauenheimApril 9, 2020
A researcher works on virus replication in order to develop a vaccine against the coronavirus COVID-19, in Belo Horizonte, state of Minas Gerais, Brazil, on March 26, 2020. - The Ministry of Health convened The Technological Vaccine Center of the Federal University of Minas Gerais laboratory to conduct research on the coronavirus COVID-19 in order to diagnose, test and develop a vaccine. (Photo by Douglas MAGNO / AFP) (Photo by DOUGLAS MAGNO/AFP via Getty Images)
CommentaryThese pharmaceutical companies are the top inventors and innovators
By IDEA PharmaApril 6, 2020
1...
  • 35
  • 36
  • 37
  • 38
  • 39
...100
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethicplaceholder alt text
By Orianna Rosa RoyleJune 24, 2026
Success
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurantsplaceholder alt text
By Orianna Rosa RoyleJune 25, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.